-
1
-
-
0030669702
-
Chemoprevention of aerodigestive cancer
-
Berwick M, Schantz S. Chemoprevention of aerodigestive cancer. Cancer Metastasis Rev 1997;16:329-47.
-
(1997)
Cancer Metastasis Rev
, vol.16
, pp. 329-347
-
-
Berwick, M.1
Schantz, S.2
-
2
-
-
33645526144
-
Cancer statistics, 2006
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
-
(2006)
CA Cancer J Clin
, vol.56
, pp. 106-130
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
3
-
-
0038441637
-
Prediction of survival with squamous cell carcinoma antigen in patients with reseable esophageal squamous cell carcinoma
-
Shimada H, Nabeya Y, Ochiai T, et al. Prediction of survival with squamous cell carcinoma antigen in patients with reseable esophageal squamous cell carcinoma. Surgery 2003;133:486-94.
-
(2003)
Surgery
, vol.133
, pp. 486-494
-
-
Shimada, H.1
Nabeya, Y.2
Ochiai, T.3
-
4
-
-
2542590283
-
Geneexpression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer
-
Tamoto E, Tada M, Murakawa K, et al. Geneexpression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 2004;10:3629-38.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3629-3638
-
-
Tamoto, E.1
Tada, M.2
Murakawa, K.3
-
5
-
-
0035467993
-
Global cancer statistics in the year 2000
-
Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
-
(2001)
Lancet Oncol
, vol.2
, pp. 533-543
-
-
Parkin, D.M.1
-
6
-
-
0034989470
-
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: The Japanese experience
-
Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-64.
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 1759-1764
-
-
Naruke, T.1
Tsuchiya, R.2
Kondo, H.3
Asamura, H.4
-
7
-
-
0028235157
-
CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group
-
Rastel D, Ramaioli A, Cornillie F, Thirion B. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group. Eur J Cancer 1994;30A:601-6.
-
(1994)
Eur J Cancer
, vol.30 A
, pp. 601-606
-
-
Rastel, D.1
Ramaioli, A.2
Cornillie, F.3
Thirion, B.4
-
8
-
-
0034306852
-
CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: Clinical utility for detection of recurrences
-
Kawaguchi H, Ohno S, Miyazaki M, et al. CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer 2000;89:1413-7.
-
(2000)
Cancer
, vol.89
, pp. 1413-1417
-
-
Kawaguchi, H.1
Ohno, S.2
Miyazaki, M.3
-
10
-
-
2942591945
-
The cancer/testis genes: Review, standardization, and commentary
-
Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004;4:1.
-
(2004)
Cancer Immun
, vol.4
, pp. 1
-
-
Scanlan, M.J.1
Simpson, A.J.2
Old, L.J.3
-
11
-
-
0038476594
-
Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice
-
Kakiuchi S, Daigo Y, Tsunoda T, Yano S, Sone S, Nakamura Y. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 2003;1:485-99.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 485-499
-
-
Kakiuchi, S.1
Daigo, Y.2
Tsunoda, T.3
Yano, S.4
Sone, S.5
Nakamura, Y.6
-
12
-
-
0038297500
-
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
-
Kikuchi T, Daigo Y, Katagiri T, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003;22:2192-205.
-
(2003)
Oncogene
, vol.22
, pp. 2192-2205
-
-
Kikuchi, T.1
Daigo, Y.2
Katagiri, T.3
-
13
-
-
19944377158
-
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
-
Kakiuchi S, Daigo Y, Ishikawa N, et al. Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet 2004;13:3029-43.
-
(2004)
Hum Mol Genet
, vol.13
, pp. 3029-3043
-
-
Kakiuchi, S.1
Daigo, Y.2
Ishikawa, N.3
-
14
-
-
33744732461
-
Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray
-
Kikuchi T, Daigo Y, Ishikawa N, et al. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. Int J Oncol 2006;28:799-805.
-
(2006)
Int J Oncol
, vol.28
, pp. 799-805
-
-
Kikuchi, T.1
Daigo, Y.2
Ishikawa, N.3
-
15
-
-
33749345478
-
Gene expression profiles of small-cell lung cancers: Molecular signatures of lung cancer
-
Taniwaki M, Daigo Y, Ishikawa N, et al. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 2006;29:567-75.
-
(2006)
Int J Oncol
, vol.29
, pp. 567-575
-
-
Taniwaki, M.1
Daigo, Y.2
Ishikawa, N.3
-
16
-
-
33747141835
-
Genome-wide gene expression profile analysis of esophageal squamous-cell carcinomas
-
Yamabuki T, Daigo Y, Kato T, et al. Genome-wide gene expression profile analysis of esophageal squamous-cell carcinomas. Int J Oncol 2006;28:1375-84.
-
(2006)
Int J Oncol
, vol.28
, pp. 1375-1384
-
-
Yamabuki, T.1
Daigo, Y.2
Kato, T.3
-
17
-
-
0036924161
-
Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray
-
Saito-Hisaminato A, Katagiri T, Kakiuchi S, Nakamura T, Tsunoda T, Nakamura Y. Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray. DNA Res 2002;9:35-45.
-
(2002)
DNA Res
, vol.9
, pp. 35-45
-
-
Saito-Hisaminato, A.1
Katagiri, T.2
Kakiuchi, S.3
Nakamura, T.4
Tsunoda, T.5
Nakamura, Y.6
-
18
-
-
0038584930
-
Expression profiles of two types of human knee joint cartilage
-
Ochi K, Daigo Y, Katagiri T, et al. Expression profiles of two types of human knee joint cartilage. J Hum Genet 2003;48:177-82.
-
(2003)
J Hum Genet
, vol.48
, pp. 177-182
-
-
Ochi, K.1
Daigo, Y.2
Katagiri, T.3
-
19
-
-
0242526157
-
Identification of COX17 as a therapeutic target for non-small cell lung cancer
-
Suzuki C, Daigo Y, Kikuchi T, Katagiri T, Nakamura Y. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res 2003;63:7038-41.
-
(2003)
Cancer Res
, vol.63
, pp. 7038-7041
-
-
Suzuki, C.1
Daigo, Y.2
Kikuchi, T.3
Katagiri, T.4
Nakamura, Y.5
-
20
-
-
11144240470
-
ADAM8 as a novel serological and histochemical marker for lung cancer
-
Ishikawa N, Daigo Y, Yasui W, et al. ADAM8 as a novel serological and histochemical marker for lung cancer. Clin Cancer Res 2004;10:8363-70.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8363-8370
-
-
Ishikawa, N.1
Daigo, Y.2
Yasui, W.3
-
21
-
-
21344437285
-
A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis
-
Kato T, Daigo Y, Hayama S, et al. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res 2005;65:5638-46.
-
(2005)
Cancer Res
, vol.65
, pp. 5638-5646
-
-
Kato, T.1
Daigo, Y.2
Hayama, S.3
-
22
-
-
23844536766
-
Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer
-
Furukawa C, Daigo Y, Ishikawa N, et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res 2005;65:7102-10.
-
(2005)
Cancer Res
, vol.65
, pp. 7102-7110
-
-
Furukawa, C.1
Daigo, Y.2
Ishikawa, N.3
-
23
-
-
27144483349
-
Increases of amphiregulin and transforming growth factor-a in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers
-
Ishikawa N, Daigo Y, Takano A, et al. Increases of amphiregulin and transforming growth factor-a in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res 2005;65:9176-84.
-
(2005)
Cancer Res
, vol.65
, pp. 9176-9184
-
-
Ishikawa, N.1
Daigo, Y.2
Takano, A.3
-
24
-
-
29244464335
-
ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway
-
Suzuki C, Daigo Y, Ishikawa N, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2005;65:11314-25.
-
(2005)
Cancer Res
, vol.65
, pp. 11314-11325
-
-
Suzuki, C.1
Daigo, Y.2
Ishikawa, N.3
-
25
-
-
33745589759
-
Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer
-
Ishikawa N, Daigo Y, Takano A, et al. Characterization of SEZ6L2 cell-surface protein as a novel prognostic marker for lung cancer. Cancer Sci 2006;97:737-45.
-
(2006)
Cancer Sci
, vol.97
, pp. 737-745
-
-
Ishikawa, N.1
Daigo, Y.2
Takano, A.3
-
26
-
-
33750323311
-
The neuromedin u-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer
-
Takahashi K, Furukawa C, Takano A, et al. The neuromedin u-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 2006;66:9408-19.
-
(2006)
Cancer Res
, vol.66
, pp. 9408-9419
-
-
Takahashi, K.1
Furukawa, C.2
Takano, A.3
-
27
-
-
33751278753
-
Activation of CDCA1-2, members of centromere protein complex, involved in pulmonary carcinogenesis
-
Hayama S, Daigo Y, Kato T, et al. Activation of CDCA1-2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res 2006;66:10339-48.
-
(2006)
Cancer Res
, vol.66
, pp. 10339-10348
-
-
Hayama, S.1
Daigo, Y.2
Kato, T.3
-
28
-
-
33846867057
-
Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer
-
Kato T, Hayama S, Yamabuki Y, et al. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res 2007;13:434-42.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 434-442
-
-
Kato, T.1
Hayama, S.2
Yamabuki, Y.3
-
29
-
-
33847381108
-
Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer
-
Suzuki C, Takahashi K, Hayama S, et al. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol Cancer Ther 2007;6:542-51.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 542-551
-
-
Suzuki, C.1
Takahashi, K.2
Hayama, S.3
-
30
-
-
34047270776
-
Dickkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas
-
Yamabuki T, Takano A, Hayama S, et al. Dickkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 2007;67:2517-25.
-
(2007)
Cancer Res
, vol.67
, pp. 2517-2525
-
-
Yamabuki, T.1
Takano, A.2
Hayama, S.3
-
31
-
-
34249327737
-
Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis
-
Hayama S, Daigo Y, Yamabuki T, et al. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Res 2007;67:4113-22.
-
(2007)
Cancer Res
, vol.67
, pp. 4113-4122
-
-
Hayama, S.1
Daigo, Y.2
Yamabuki, T.3
-
32
-
-
34548779762
-
Activation of holiday junction-recognizing protein involved in the chromosomal stability and immortality of cancer cells
-
Kato T, Sato N, Hayama S, et al. Activation of holiday junction-recognizing protein involved in the chromosomal stability and immortality of cancer cells. Cancer Res 2007;67:8544-53.
-
(2007)
Cancer Res
, vol.67
, pp. 8544-8553
-
-
Kato, T.1
Sato, N.2
Hayama, S.3
-
33
-
-
36749076543
-
Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer
-
In press
-
Taniwaki M, Takano A, Ishikawa N, et al. Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer. Clin Cancer Res. In press 2007.
-
(2007)
Clin Cancer Res
-
-
Taniwaki, M.1
Takano, A.2
Ishikawa, N.3
-
34
-
-
0037352493
-
Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma
-
de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, et al. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer 2003;103:768-74.
-
(2003)
Int J Cancer
, vol.103
, pp. 768-774
-
-
de Nooij-van Dalen, A.G.1
van Dongen, G.A.2
Smeets, S.J.3
-
35
-
-
34848895621
-
LY-6K gene: A novel molecular marker for human breast cancer
-
Lee JW, Lee YS, Yoo KH, et al. LY-6K gene: a novel molecular marker for human breast cancer. Oncol Rep 2006;16:1211-4.
-
(2006)
Oncol Rep
, vol.16
, pp. 1211-1214
-
-
Lee, J.W.1
Lee, Y.S.2
Yoo, K.H.3
-
37
-
-
10744219973
-
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples
-
Chin SF, Daigo Y, Huang HE, et al. A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. Mol Pathol 2003;56:275-9.
-
(2003)
Mol Pathol
, vol.56
, pp. 275-279
-
-
Chin, S.F.1
Daigo, Y.2
Huang, H.E.3
-
38
-
-
0037284614
-
Molecular classification of breast carcinomas using tissue microarrays
-
Callagy G, Cattaneo E, Daigo Y, et al. Molecular classification of breast carcinomas using tissue microarrays. Diagn Mol Pathol 2003;12:27-34.
-
(2003)
Diagn Mol Pathol
, vol.12
, pp. 27-34
-
-
Callagy, G.1
Cattaneo, E.2
Daigo, Y.3
-
39
-
-
13844281018
-
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays
-
Callagy G, Pharoah P, Chin SF, et al. Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J Pathol 2005;205:388-96.
-
(2005)
J Pathol
, vol.205
, pp. 388-396
-
-
Callagy, G.1
Pharoah, P.2
Chin, S.F.3
-
40
-
-
0038054270
-
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
-
Nakatsura T, Yoshitake Y, Senju S, et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 2003;306:16-25.
-
(2003)
Biochem Biophys Res Commun
, vol.306
, pp. 16-25
-
-
Nakatsura, T.1
Yoshitake, Y.2
Senju, S.3
-
41
-
-
0029020752
-
Overexpressed Ly-6A.2 mediates cell-cell adhesion by binding a ligand expressed on lymphoid cells
-
Bamezai A, Rock KL. Overexpressed Ly-6A.2 mediates cell-cell adhesion by binding a ligand expressed on lymphoid cells. Proc Natl Acad Sci U S A 1995;92:4294-8.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 4294-4298
-
-
Bamezai, A.1
Rock, K.L.2
-
42
-
-
0030923882
-
Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas
-
Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, Testa JR. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 1997;57:2116-20.
-
(1997)
Cancer Res
, vol.57
, pp. 2116-2120
-
-
Balsara, B.R.1
Sonoda, G.2
du Manoir, S.3
Siegfried, J.M.4
Gabrielson, E.5
Testa, J.R.6
-
43
-
-
76549177140
-
Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques
-
Gold P, Freedman S. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-62.
-
(1965)
J Exp Med
, vol.121
, pp. 439-462
-
-
Gold, P.1
Freedman, S.2
-
44
-
-
0033057177
-
The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues
-
Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9:67-81.
-
(1999)
Semin Cancer Biol
, vol.9
, pp. 67-81
-
-
Hammarstrom, S.1
-
46
-
-
0142008426
-
Expression of CEACAM6 in resectable colorectal cancer: A factor of independent prognostic significance
-
Jantscheff P, Terracciano L, Lowy A, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 2003;21:3638-46.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3638-3646
-
-
Jantscheff, P.1
Terracciano, L.2
Lowy, A.3
-
47
-
-
13144250150
-
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
-
Reiter RE, Gu Z, Watabe T, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A 1998;95:1735-40.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 1735-1740
-
-
Reiter, R.E.1
Gu, Z.2
Watabe, T.3
-
48
-
-
20044364936
-
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas
-
Marshall JL, Gulley JL, Arlen PM, et al. Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J Clin Oncol 2005;23:720-31.
-
(2005)
J Clin Oncol
, vol.23
, pp. 720-731
-
-
Marshall, J.L.1
Gulley, J.L.2
Arlen, P.M.3
-
49
-
-
0036569591
-
Prostate stem cell antigen as therapy target: Tissue expression and in vivo efficacy of an immunoconjugate
-
Ross S, Spencer SD, Holcomb I, et al. Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 2002;62:2546-53.
-
(2002)
Cancer Res
, vol.62
, pp. 2546-2553
-
-
Ross, S.1
Spencer, S.D.2
Holcomb, I.3
-
50
-
-
0035956985
-
Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts
-
Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci U S A 2001;98:2658-63.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 2658-2663
-
-
Saffran, D.C.1
Raitano, A.B.2
Hubert, R.S.3
Witte, O.N.4
Reiter, R.E.5
Jakobovits, A.6
|